Q

Qiagen NV

D
QGEN
USD
-0.09
(-0.197%)
Market Closed
45,080.00
Volume
2.1655
EPS
-
Div Yield
131.878
P/E
10,134,326,400.00
Market Cap
Today
-0.1970%
1 Week
0.088%
1 Month
-2.855%
6 Months
3.519%
12 Months
10.304%
Year To Date
1.835%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
TMO
TMO
10.31
(1.6903%)
USD
L
LH
-2.54
(-1.1184%)
USD
BDX
BDX
3.02
(1.304%)
USD
TTD
TTD
2.08
(1.9252%)
USD
IDXX
IDXX
5.77
(1.1287%)
USD
Z
ZBH
-0.01
(-0.0094%)
USD
DHR
DHR
4.69
(1.7253%)
USD
H
HOLX
0.64
(0.7831%)
USD
D
DGX
-0.37
(-0.238%)
USD
P
PKI
1.92
(1.5668%)
USD

Title:
Qiagen NV

Sector:
Healthcare
Industry:
Diagnostics & Research
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
Do you need help or have a question?
Contact Us